+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Clinical evaluation of broncho-vaxom efficiency



Clinical evaluation of broncho-vaxom efficiency



Polski Tygodnik Lekarski 46(22-23): 422-423



Broncho-vaxom was administered to 40 patients with recurrent respiratory infections, allergic-infectious bronchial asthma and chronic bronchitis. Broncho-vaxom was administered in the dose of one capsule for the first month, and 1 capsule for 10 days in the third, fourth, and fifth month. A favourable clinical effect has been achieved in over 50% of the treated patients manifested by the decrease in the number and severity of respiratory infections and reductions in antibiotics use. These results confirm clinical efficiency of this vaccine.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 039571246

Download citation: RISBibTeXText

PMID: 1669081


Related references

Attempt with oral immunobiotherapy (broncho-vaxom) and immunochemotherapy (broncho-vaxom + neomycin) for the elimination of bacteria in symptom-free "other Salmonella" carriers. Therapia Hungarica 37(4): 209-215, 1989

The immunomodulators broncho vaxom and uro vaxom stimulate the bacterial killing and oxidative metabolism of polymorphonuclear leukocytes by the activation of phosphatidylinositol turnover. International Journal of Experimental & Clinical Chemotherapy 4(1): 1-11, 1991

The use of broncho-vaxom preparation in clinical practice. Polski Merkuriusz Lekarski 14(83): 457-458, 2003

Broncho-Vaxom in children with rhinosinusitis: a double-blind clinical trial. Orl; Journal for Oto-Rhino-Laryngology and its Related Specialties 50(6): 397-404, 1988

Multicenter clinical trial of broncho vaxom in chronic bronchitis and asthma. Acta Therapeutica 17(3): 273-282, 1991

Double blind multicenter clinical study with broncho vaxom in chronic bronchitis. European Respiratory Journal 1(Suppl. 2): 252S, 1988

Clinical effectiveness of Broncho-Vaxom (BV) in patients with chronic obstructive pulmonary disease. International Journal of Immunotherapy 9(2): 135-142, 1993

Broncho vaxom in the treatment of recurrent bronchitis and bronchial asthma a controlled clinical trial. Clinical Trials Journal 26(5): 325-334, 1989

Influence of a bacterial extract, Broncho-Vaxom, on clinical and immunological parameters in patients with intrinsic asthma. International Journal of Immunotherapy 9(2): 127-133, 1993

Double-blind clinical study with broncho-vaxom in the treatment of recurrent acute bronchitis and bronchial asthma. International Journal of Immunotherapy 8(3): 153-159, 1992

Effect of a bacterial lysate (Broncho-Vaxom) in the therapy of chronic bronchitis: multi-center double-blind clinical trial. Revue Medicale de la Suisse Romande 101(2): 143-146, 1981

Clinical efficacy of broncho vaxom in adult patients with chronic purulent sinusitis a placebo controlled double blind study. Archives of Oto-Rhino-Laryngology 246(6): 456, 1989

Effect of broncho vaxom on clinical and immunological parameters in patients with chronic obstructive bronchitis a double blind placebo controlled study. International Journal of Immunotherapy 5(3): 139-143, 1989

Study on clinical effect and immunologic mechanism of infants capillary bronchitis secondary bronchial asthma treated with bacterial lysates Broncho-Vaxom. European Review for Medical and Pharmacological Sciences 20(10): 2151-2155, 2016

Efficacy of the immunostimulant Broncho-Vaxom. Schweizerische Medizinische Wochenschrift 114(25): 932-934, 1984